Bristol myers squibb's car t cell therapy breyanzi approved by the u.s. food and drug administration for relapsed or refractory follicular lymphoma

Princeton, n.j.--(business wire)---- $bmy #breyanzi--bristol myers squibb's car t cell therapy breyanzi approved by the u.s. food and drug administration for relapsed or refractory follicular lymphoma.
CAR Ratings Summary
CAR Quant Ranking